ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020
Should Flow Cytometry Be Considered a First Line of Study in the Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma?
Abstract readLetterComment
In one paragraph
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 8 citations in OpenAlex.
- Article
- Flow Cytometry Analysis in Breast Implant-Associated Anaplastic Large Cell Lymphoma: Three Case Reports.International journal of molecular sciences · 2024Article
- Breast implant associated anaplastic large cell lymphoma: Evidence for an efficient diagnostic workup.Tumori · 2023Article
- Breast Implanted-Associated Anaplastic Large Cell Lymphoma: A Case of Advanced Disease with Flow Cytometric Findings.International journal of surgical pathology · 2023Article
- Current Progress in Breast Implant-Associated Anaplastic Large Cell Lymphoma.Frontiers in oncology · 2021Review
- Reply to M. Romero et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
11 authors at 1 institution in 1 country.
Martha RomeroMartha Romero, MD, PhD; Andrés Melo, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; Nelson Bedoya, MD, Department of Radiology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; José de la Hoz, MD, Department of Clinical Studies, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; and Marcela Mejía-Arango, MD; Karen Galvis, MD; Luz Hernandez, BS; Gina Cuellar, BS; Liliana Martin, BS; Sandra Quijano, PhD; Carlos Saavedra, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Andrés MeloMartha Romero, MD, PhD; Andrés Melo, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; Nelson Bedoya, MD, Department of Radiology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; José de la Hoz, MD, Department of Clinical Studies, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; and Marcela Mejía-Arango, MD; Karen Galvis, MD; Luz Hernandez, BS; Gina Cuellar, BS; Liliana Martin, BS; Sandra Quijano, PhD; Carlos Saavedra, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Nelson BedoyaMartha Romero, MD, PhD; Andrés Melo, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; Nelson Bedoya, MD, Department of Radiology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; José de la Hoz, MD, Department of Clinical Studies, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; and Marcela Mejía-Arango, MD; Karen Galvis, MD; Luz Hernandez, BS; Gina Cuellar, BS; Liliana Martin, BS; Sandra Quijano, PhD; Carlos Saavedra, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
José de la HozMartha Romero, MD, PhD; Andrés Melo, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; Nelson Bedoya, MD, Department of Radiology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; José de la Hoz, MD, Department of Clinical Studies, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; and Marcela Mejía-Arango, MD; Karen Galvis, MD; Luz Hernandez, BS; Gina Cuellar, BS; Liliana Martin, BS; Sandra Quijano, PhD; Carlos Saavedra, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Marcela Mejía-ArangoMartha Romero, MD, PhD; Andrés Melo, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; Nelson Bedoya, MD, Department of Radiology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; José de la Hoz, MD, Department of Clinical Studies, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; and Marcela Mejía-Arango, MD; Karen Galvis, MD; Luz Hernandez, BS; Gina Cuellar, BS; Liliana Martin, BS; Sandra Quijano, PhD; Carlos Saavedra, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Karen GalvisMartha Romero, MD, PhD; Andrés Melo, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; Nelson Bedoya, MD, Department of Radiology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; José de la Hoz, MD, Department of Clinical Studies, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; and Marcela Mejía-Arango, MD; Karen Galvis, MD; Luz Hernandez, BS; Gina Cuellar, BS; Liliana Martin, BS; Sandra Quijano, PhD; Carlos Saavedra, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Luz HernandezMartha Romero, MD, PhD; Andrés Melo, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; Nelson Bedoya, MD, Department of Radiology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; José de la Hoz, MD, Department of Clinical Studies, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; and Marcela Mejía-Arango, MD; Karen Galvis, MD; Luz Hernandez, BS; Gina Cuellar, BS; Liliana Martin, BS; Sandra Quijano, PhD; Carlos Saavedra, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Gina CuellarMartha Romero, MD, PhD; Andrés Melo, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; Nelson Bedoya, MD, Department of Radiology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; José de la Hoz, MD, Department of Clinical Studies, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; and Marcela Mejía-Arango, MD; Karen Galvis, MD; Luz Hernandez, BS; Gina Cuellar, BS; Liliana Martin, BS; Sandra Quijano, PhD; Carlos Saavedra, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Liliana MartinMartha Romero, MD, PhD; Andrés Melo, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; Nelson Bedoya, MD, Department of Radiology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; José de la Hoz, MD, Department of Clinical Studies, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; and Marcela Mejía-Arango, MD; Karen Galvis, MD; Luz Hernandez, BS; Gina Cuellar, BS; Liliana Martin, BS; Sandra Quijano, PhD; Carlos Saavedra, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Sandra QuijanoMartha Romero, MD, PhD; Andrés Melo, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; Nelson Bedoya, MD, Department of Radiology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; José de la Hoz, MD, Department of Clinical Studies, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; and Marcela Mejía-Arango, MD; Karen Galvis, MD; Luz Hernandez, BS; Gina Cuellar, BS; Liliana Martin, BS; Sandra Quijano, PhD; Carlos Saavedra, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Carlos SaavedraMartha Romero, MD, PhD; Andrés Melo, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; Nelson Bedoya, MD, Department of Radiology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; José de la Hoz, MD, Department of Clinical Studies, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia; and Marcela Mejía-Arango, MD; Karen Galvis, MD; Luz Hernandez, BS; Gina Cuellar, BS; Liliana Martin, BS; Sandra Quijano, PhD; Carlos Saavedra, MD, Department of Pathology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Fundación Santa Fe de Bogotá · CO
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Breast ImplantsBreast NeoplasmsLymphoma, Large-Cell, AnaplasticFlow CytometryHumans
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.